Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 57, Issue 9, Pages 1660-1670Publisher
WILEY
DOI: 10.1002/mnfr.201300130
Keywords
Akt; Alzheimer's disease; Glutathione; Nrf2; Sirtuins
Categories
Funding
- NSERC
- Foundation Armand-Frappier
- GPD from AUF
Ask authors/readers for more resources
Scope: The aim of the present study was to examine the neuroprotective effect of curcumin against the toxicity induced by acrolein and to identify its cellular mechanisms and targets. Methods and resultsHuman neuroblastoma cells SK-N-SH were treated with acrolein. Curcumin, from 5 M, was able to protect SK-N-SH cells against acrolein toxicity. The addition of curcumin restored the expression of -glutamylcysteine synthetase, reactive oxygen species, and reactive nitrogen species levels but had no effect on the decrease of glutathione (GSH) and on the elevation of protein carbonyls. Acrolein induced the activity of Nrf2, NF-B, and Sirt1. These activations were prevented by the presence of curcumin. Acrolein also induced a decrease of the pAkt, which was counteracted by curcumin. To increase its solubility, we have encapsulated curcumin in a biodegradable poly(lactide-co-glycolide) based nanoparticulate formulation (Nps-Cur). Our results showed that 0.5 M of Nps-Cur can protect neuronal cells challenged with acrolein while free curcumin was not able to display neuroprotection. ConclusionOur results provided evidence that curcumin was able to protect SK-N-SH cells against acrolein toxicity. This protection is mediated through the antioxidant, the redox, and the survival regulated pathways by curcumin. Moreover, our results demonstrated that Nps-Cur had higher capacity than curcumin to protect SK-N-SH cells against acrolein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available